PERSONAL SUMMARY：
QUALIFICATION
Patent Attorney (2012)
Attorney at law (2015)
EDUCATION
The John Marshall Law School (LL.M. in Intellectual Property
Law with honors, 2017)
Peking University (Ph.D. in Medicinal Chemistry, 2010)
Peking University (Bachelor in Pharmaceutical Science,
2004)
INTRODUCTION
Dr. Mou is a partner
at Liu, Shen & Associates, who was qualified as attorney at law and patent
attorney, and is experienced in the analysis and mining, global protection
strategy, patent portfolio management, legal consulting, due diligence, and
dispute resolution of patents, as well as the management and protection of
trade secret.
Before joining
Liu, Shen & Associates in 2010, Dr. Mou had a one year experience of
R&D in the HIV department of GSK in NC, USA. He also worked for Bayer China
Limited with the IP affairs in 2015.
Dr. Mou has a good scientific background in
the pharmaceutical industry and legal knowledge in IP related laws and
regulations, fully understanding the business strategy, scientific development,
and legal protection of the drugs, and has experiences in global portfolio and
protection strategy in about 20 countries including China, U.S., Japan, Europe,
Korea and others.
HIGHLIGHTS：
Dispute resolution
- A
university in the U.S. vs. Chinese Patent Office, representing the university
attending the first and second instance trials of the administrative proceeding
(2018-2020)
- A MNC
pharmaceutical company vs. its distributor, representing the pharmaceutical
company invalidating patents of the distributor (2020-2021)
- Representing
Pfizer and successfully defending the patent covering a commercial polymorph
(2019)
- Involving
in an arbitration case between a domestic pharmaceutical company and an
American company (2020)
- Involving
in the negotiation of trade secret affairs between a domestic pharmaceutical
company and an American company (2019)
Legal consulting
- Providing
the due diligence services to a domestic Life Sciences Group Co., Ltd. for investing a
company (2020)
- Supporting
the IP affairs of a company in Shenzhen for capital injection (2019 and 2020)
- Analyzing
the marketing of generics of a drug for a company in Shenzhen (2020)
- Providing
legal opinions to a company in Suzhou for licensing-in a clinical candidate
from an American company (2020)
- Providing
suggestions regarding the management and portfolio strategy of patents for a
startup in Shanghai (2020)
- Providing
strategy of patent portfolio management for a listed company in Shanghai (2020)
- Providing
the due diligence service for a pharmaceutical company in Beijing (2020)
- Providing
comments on fighting against patent infringement for Tsinghua University (2020)
- Providing
legal comments on patent portfolio for a company in Henan (2020)
- Drafting
Non-disclosure agreement for a company in Shenzhen (2019)
- Providing
advice regarding management and protection of trade secret for a company in Fujian
(2018)
Presentations and Publications
- Enforcement
of Trade Secrets: The Practical Realities (AIPPI 2020 World Congress)
- The
Management and Protection of Trade Secret Assets from the Perspective of
Business Competition (2020)
- Rational
protecting measures for trade secret protection (2020)
- Judgments
of the trade secret cases from the Supreme Court (2017)
- Introduction
to three approaches to expedite patent prosecution (2020)
- Amending
a Markush claim in an invalidation procedure becomes more difficult (2018)
- Practice
and tips in drafting a pharmaceutical patent (2018)
- Legal
concepts and its purposeful explanation (2017)
